<?xml version="1.0" encoding="UTF-8"?>
<p>The in vitro antiviral assay showed 
 <italic>N</italic>-{3-(methylthio)-1-[5-(phenylamino)-1,3,4-thiadiazol-2-yl]propyl}benzamide 
 <bold>45</bold> as an Influenza A H
 <sub>3</sub>N
 <sub>2</sub> virus subtype inhibitor. With an EC
 <sub>50</sub> value of 31.4 Î¼M, the derivative 
 <bold>45</bold> was the most potent among the tested compounds and moderate active compared to standard drug oseltamivir, but a promising scaffold for future developments. Derivatives 
 <bold>47</bold> and 
 <bold>48</bold> exhibited activity against Parainfluenza-3 and Reovirus-1 and probably the thiourea moiety favors antiviral activity on these strains (
 <xref ref-type="fig" rid="molecules-25-00942-f005">Figure 5</xref>) [
 <xref rid="B49-molecules-25-00942" ref-type="bibr">49</xref>].
</p>
